SCHEMBL27293104

SCHEMBL27293104

CC(C)CN(C)CC(=O)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA9 Q16790 1/20 0.35
PIK3CD O00329 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26382115 0.81 HSD11B1 (0.34)
SCHEMBL26003256 0.77
SCHEMBL15498540 0.75 KMT2A (0.30)
SCHEMBL10934770 0.75 CA12 (0.39) CA12CA1CA2CA9PIK3CD
SCHEMBL10044471 0.75 ALDH1A1 (0.42) CA12CA1CA2CA9PIK3CD
SCHEMBL16981999 0.74 CYP2D6 (0.36) CA12CA1CA2CA9PIK3CD
SCHEMBL15498610 0.73 TDP1 (0.35)
SCHEMBL12977350 0.73 CA1 (0.38) CA12CA1CA2CA9PIK3CD
SCHEMBL8417238 0.73 CA1 (0.38) CA12CA1CA2CA9PIK3CD
SCHEMBL12448092 0.73 CA1 (0.38) CA12CA1CA2CA9PIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023250513-A1 13-MEMBERED MACROLIDE COMPOUNDS FOR TREATING DISEASES MEDIATED BY ABNORMAL PROTEIN TRANSLATION ZIKANI THERAPEUTICS, INC. (US) 2023-12-28 WO disclosed